Chordoma is a rare type of bone cancer. It occurs in the skull base or spine. Researchers want to study people with chordoma in different ways. They hope this will help them design better future treatments and supportive care studies for this disease.
To learn more about chordoma by looking at its clinical course, how it appears on imagine scans, and how it responds to therapies and treatments.
People ages 2 and older with chordoma who are enrolled in NCI protocol 19-C-0016
Participants will be screened with their medical history.
Participants will have a visit to examine their disease. This will include:
Participants will have other tests every 6-12 months:
Participants or their home doctors will be contacted every 6 12 months. They will be asked to provide information about their disease. This could include test results and imaging evaluations.
Some participants may be asked to come to the clinic for more visits.
-For chordomas that cannot be surgically resected, treatment options are limited. Currently,
no standard therapy approach exists for recurrent chordomas. In addition, there are no FDA approved medical therapies for chordoma.
-To characterize the natural history of chordoma, including clinical presentation and patterns of disease progression.
-This protocol is a subprotocol to protocol 19-C-0016: Natural History and Biospecimen
Acquisition Study for Children and Adults with Rare Solid Tumors . After enrollment on the master protocol and undergoing evaluations detailed, patients will be enrolled on this subprotocol specific for chordoma.
-Medical histories will be documented, and patients followed throughout the course of their disease, with particular attention to patterns of disease recurrence and progression, response to therapies, duration of responses and patient reported outcomes. Tumor growth rates will also be calculated throughout the course of the disease.
|Clinical Study Identifier||NCT03910465|
|Sponsor||National Cancer Institute (NCI)|
|Last Modified on||11 May 2020|
Select a piece of text and start making personal notes.
You have contacted , on
Your message has been sent to the study team at ,
Additional screening procedures may be conducted by the study team before you can be confirmed eligible to participate.Learn more
If you are confirmed eligible after full screening, you will be required to understand and sign the informed consent if you decide to enroll in the study. Once enrolled you may be asked to make scheduled visits over a period of time.Learn more
Complete your scheduled study participation activities and then you are done. You may receive summary of study results if provided by the sponsor.Learn more
Congrats! You have your own personal workspace now.